日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer

外周血单核细胞中的趋化因子受体作为非小细胞肺癌免疫治疗疗效的预测性生物标志物

Galera, Paloma; Iglesias-Beiroa, Antía; Hernández-Marín, Berta; Bañón, Dulce; Arangoa, Teresa; Castillo, Lucía; Álvarez-Maldonado, María; Gil-Olarte, Cristina; Borregón, Rafael; Iribarren, María; Colomer, Ramon; Rogado, Jacobo

Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

2024年乳腺癌生物标志物:西班牙肿瘤内科学会和西班牙病理学会的最新共识声明

Colomer, Ramon; González-Farré, Blanca; Ballesteros, Ana Isabel; Peg, Vicente; Bermejo, Begoña; Pérez-Mies, Belén; de la Cruz, Susana; Rojo, Federico; Pernas, Sonia; Palacios, José

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

下一代测序检测在癌症患者中的实用性和实际应用效果:一项关于基于临床判断的选择影响的观察性研究

Colomer, Ramon; Miranda, Jesús; Romero-Laorden, Nuria; Hornedo, Javier; González-Cortijo, Lucía; Mouron, Silvana; Bueno, Maria J; Mondéjar, Rebeca; Quintela-Fandino, Miguel

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer

BERENICE 最终分析:新辅助帕妥珠单抗、曲妥珠单抗和化疗后序贯辅助帕妥珠单抗和曲妥珠单抗治疗 HER2 阳性早期乳腺癌的心脏安全性研究

Dang, Chau; Ewer, Michael S; Delaloge, Suzette; Ferrero, Jean-Marc; Colomer, Ramon; de la Cruz-Merino, Luis; Werner, Theresa L; Dadswell, Katherine; Verrill, Mark; Eiger, Daniel; Sarkar, Sriparna; de Haas, Sanne Lysbet; Restuccia, Eleonora; Swain, Sandra M

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.

外周血单核细胞可预测非小细胞肺癌免疫疗法的疗效

Rogado Jacobo, Pozo Fernando, Troule Kevin, Sánchez-Torres José Miguel, Romero-Laorden Nuria, Mondejar Rebeca, Donnay Olga, Ballesteros Anabel, Pacheco-Barcia Vilma, Aspa Javier, Al-Shahrour Fátima, Alfranca Arantzazu, Colomer Ramon

When should we order a next generation sequencing test in a patient with cancer?

我们应该在什么情况下为癌症患者进行下一代测序检测?

Colomer, Ramon; Mondejar, Rebeca; Romero-Laorden, Nuria; Alfranca, Arantzazu; Sanchez-Madrid, Francisco; Quintela-Fandino, Miguel

Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies

超重和免疫相关不良事件对PD-1抗体抗癌免疫疗法疗效的影响

Rogado, Jacobo; Romero-Laorden, Nuria; Sanchez-Torres, José Miguel; Ramos-Levi, Ana María; Pacheco-Barcia, Vilma; Ballesteros, Ana Isabel; Arranz, Reyes; Lorenzo, Alicia; Gullon, Pedro; Garrido, Ana; Serra López-Matencio, José María; Donnay, Olga; Adrados, Magdalena; Costas, Pablo; Aspa, Javier; Alfranca, Arantzazu; Mondejar, Rebeca; Colomer, Ramon

Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

早期乳腺癌新辅助治疗:临床和研究立场声明

Colomer, Ramon; Saura, Cristina; Sánchez-Rovira, Pedro; Pascual, Tomás; Rubio, Isabel T; Burgués, Octavio; Marcos, Lourdes; Rodríguez, César A; Martín, Miguel; Lluch, Ana

Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome

恶性黑色素瘤骨骼肌和孤立性骨转移:多模态影像学及肿瘤学预后

Gómez-León, Nieves; Pacheco-Barcia, Vilma; Ballesteros, Ana I; Fraga, Javier; Colomer, Ramon; Friera, Alfonsa

A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms

脂肪酸合成酶抑制剂展现新的抗癌机制

Bueno, Maria J; Colomer, Ramon